About National Center for Geriatrics and Gerontology
国立研究開発法人国立長寿医療研究センターは、日本の厚生労働省所管の国立研究開発法人である。愛知県大府市に設置されている。2004年3月1日に、長寿医療を扱う6番目のナショナルセンターとして、旧国立療養所中部病院の地に国立長寿医療センターとして設立された。2010年に独立行政法人に移行した。
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at National Center for Geriatrics and Gerontology
During the past decade, National Center for Geriatrics and Gerontology conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on
average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "National Center for Geriatrics and Gerontology"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at National Center for Geriatrics and Gerontology
According to Clinical.Site data, the most researched conditions in "National Center for Geriatrics and Gerontology" are
"Alzheimer Disease" (5 trials), "Alzheimer's Disease" (2 trials), "Alzheimer Disease (AD)" (1 trials), "Alzheimer´s Disease" (1 trials) and "Nocturia" (1 trials). Many other conditions were trialed in "National Center for Geriatrics and Gerontology" in a lesser frequency.
Clinical Trials Intervention Types at National Center for Geriatrics and Gerontology
Most popular intervention types in "National Center for Geriatrics and Gerontology" are "Drug" (10 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Donanemab" (2 trials), "Gantenerumab" (2 trials), "Lanabecestat" (2 trials) and "Crenezumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at National Center for Geriatrics and Gerontology
The vast majority of trials in "National Center for Geriatrics and Gerontology" are
10 trials for "All" genders.
Clinical Trials Status at National Center for Geriatrics and Gerontology
Currently, there are NaN active trials in "National Center for Geriatrics and Gerontology".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in National Center for Geriatrics and Gerontology,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in National Center for Geriatrics and Gerontology, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".